Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss

v3.20.2
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Income Statement [Abstract]        
Revenue $ 2,264 $ 3,262 $ 3,731 $ 6,878
Cost of revenue 1,005 1,702 1,835 3,719
Gross profit 1,259 1,560 1,896 3,159
Operating expenses:        
Sales and marketing 1,712 3,039 4,232 5,848
Research and development 452 1,499 1,163 2,883
General and administrative 1,943 2,120 4,130 4,438
Restructuring 244 0 244 0
Total operating expenses 4,351 6,658 9,769 13,169
Loss from operations (3,092) (5,098) (7,873) (10,010)
Other (expense) income, net:        
Interest expense (38) (107) (90) (228)
(Loss) gain on revaluation of warrant liabilities (8,574) 2,737 (6,055) 1,615
Loss on modification of warrant 0 0 0 (257)
Warrant issuance expense (329) (706) (329) (706)
Other income (expense), net 266 108 46 (31)
Total other (expense) income, net (8,675) 2,032 (6,428) 393
Net loss (11,767) (3,066) (14,301) (9,617)
Other comprehensive (loss) income (193) (106) (20) 42
Comprehensive loss $ (11,960) $ (3,172) $ (14,321) $ (9,575)
Basic and diluted net loss per share applicable to common shareholders (in dollars per share) $ (1.88) $ (0.65) $ (2.37) $ (2.12)
Weighted average number of shares outstanding, basic and diluted (in shares) 6,261 4,713 6,032 4,526